High exposure to harmful chemical impacts thyroid hormones in pregnant mothers
Studies conducted by Assistant Professor, Zeyan Liew, at the Yale School of Public Health, focus on a group of harmful chemicals known as PFAS (per- and polyfluoroalkyl substances) that can affect hormones during pregnancy crucial to fetal development. Efforts are underway by Yale professors, Dr. Krystal Pollitt and Dr. John Fortner, to investigate the chemical structures and ban the use of PFAS as well as determine routes for removing or destroying the substances from the environment.Source: Yale Daily News
Study: Accuracy of Five Self‐Report Screening Instruments for Substance Use in Pregnancy
Nearly one-fourth of pregnant women report having used alcohol, tobacco, or other substances in the past month, yet current screening questionnaires used by physicians may not accurately identify many of them. Kimberly A. Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services at Yale School of Medicine, was the senior researcher among investigators across three universities who compared results of five commonly used questionnaires against laboratory testing.
Better Science, Better Lives: Women's Health Research at Yale is Working for You
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
Don't Jump for Joy over New FDA-approved Postpartum Depression Medicine Yet
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Sciences cautions new mothers who may consider taking the new FDA-approved medication for postpartum depression in an opinion piece published in USA Today.Source: USA Today
Study Links Depression During Pregnancy, Risky Postpartum Sexual Behavior
Depression is one of the most common complications of pregnancy, but the focus is typically on postpartum depression. Now, the Yale School of Public Health has found that among young, urban women of color, depressive symptoms can start during pregnancy and can be a precursor to risky sexual behavior after a baby is born.
A paradox of approval with the HPV vaccine
Parents are hesitant to have their own children vaccinated against the Human Papilloma Virus at the appropriate age — 11 to 12 years — despite approving of the age guidelines recommended by the Centers for Disease Control and Prevention, a new study from the Yale School of Public Health finds.Source: Yale Daily News
Lower Levels of Alcohol Consumption While Pregnant are Not Associated with Increased Risk of Poor Birth Outcomes
Heavy alcohol consumption during pregnancy has long been linked to a range of developmental problems and birth defects including fetal alcohol syndrome (FAS), but a new study led by Yale researchers shows that low to moderate alcohol consumption is not associated with an increased risk for specific birth outcomes and measures of fetal growth.
Research in the news: Progesterone may be effective treatment for cocaine-addicted women after childbirth
Cocaine-addicted women typically decrease drug use during pregnancy. This is also the time when concentrations of progesterone are high. After delivery, when progesterone levels drop, women with addiction are likely to relapse. New research suggests that administering progesterone to these post-partum women helps prevent this relapse. The findings appear online ahead of print in Lancet Psychiatry.
WHRY Funds Studies on Stroke, Endometrial Cancer, and Addiction to Opioids
Women’s Health Research at Yale today announced funding for three studies investigating sex differences in stroke, endometrial cancer, and alternate pain relief for women recovering from past opioid use who are giving birth via cesarean section.
HEALTH NOTES: Aggressive Uterine Cancer Rates Are Rising in the U.S., Especially for Minority Women
Women in the United States have experienced a steep rise in rates of aggressive uterine cancer since 2000, an upward trend that has been particularly steep for minority women, according to a new study.
Iwasaki Is Honored by the International Cytokine & Interferon Society
Akiko Iwasaki, PhD, Waldemar Von Zedtwitz Profesor of Immunobiology and Molecular, Cellular, and Developmental Biology; and professor of dermatology, is a 2019 recipient of the Seymour & Vivian Milstein Award for Excellence in Interferon and Cytokine Research, given by the International Cytokine & Interferon Society (ICIS).
Improving the Health of Pregnant Women
More than six million women are pregnant in the United States in any given year, and more than 90 percent of these women will take at least one medication. But clinical studies of medications, diseases, and conditions often exclude pregnant and lactating women, leaving women and their caregivers guessing about how pregnancy and childbirth affect the efficacy and safety of particular treatments.
Preventing Viral Infections During Pregnancy
Dr. Michelle Silasi, Assistant Professor of Obstetrics, Gynecology, and Reproductive Sciences, will test the effectiveness of a new technique to screen for viral exposure during pregnancy that can identify women at risk for serious complications and allow for interventions to improve pregnancy outcomes.